XJPX
4218
Market cap236mUSD
Jul 10, Last price
1,897.00JPY
1D
-0.47%
1Q
0.05%
Jan 2017
17.10%
Name
Nichiban Co Ltd
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Nichiban Co., Ltd. operates as a manufacturer and distributor of medical supplies and various adhesive tapes across Asian and European markets. Its range of medical offerings encompasses products like surgical and dressing tapes, alongside first-aid and hemostatic bandages. The company also provides over-the-counter (OTC) solutions, which include anti-inflammatory patches, foot care items, waterproof films, and general bandages. For athletic and support needs, Nichiban supplies an assortment of taping products such as cotton, elastic, kinesiology, and strapping tapes. Within its stationery division, the company offers cellulose adhesive tapes, double-sided tapes, adhesive transfer tapes, and book-binding tapes. Furthermore, Nichiban produces industrial tapes tailored for diverse applications, including non-heavy-duty packaging, carton sealing, agricultural use, vehicles, and machinery, in addition to specialized tape solutions. The company's tape portfolio also features cellulose, OPP packing, kraft paper, lithographic, and crepe tapes. Founded in 1918, Nichiban Co., Ltd. maintains its headquarters in Tokyo, Japan.
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026‑03 | 2025‑03 | 2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||